U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296094) titled 'Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder' on Dec. 12.
Brief Summary: This study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will undergo structured psychotherapy and will be randomized to two psilocybin sessions to receive either a full dose (30mg or 40mg) or low dose (10mg or 15mg).
Study Start Date: May 01, 2026
Study Type: INTERVENTIONAL
Condition:
Alcohol Use Disorder...